Latest filing published 25 Aug 2009 for IMARX THERAPEUTICS INC.
Insider track record
No signal scores available.
Richard E. Otto: trading record in brief
Richard E. Otto discloses dealings in Imarx Therapeutics Inc to SEC (Form 4). We count 3 filings; the first trade dates from 31 July 2007 and the latest from 21 August 2009.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 25 August 2009, the filings show a share grant in Imarx Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Richard E. Otto
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 300,000 shares0Common StockSEC:0000893877-09-000312:0
- 23,810 shares0Common StockSEC:0001406497-08-000003:0
- 5,000 shares@ US$5.00Common StockSEC:0001406497-07-000005:0
3 of 3 declarations